-
-
Raising the bar through leadership: MS Leaders Academy
-
Posted in Courses & Conferences
-
19th Mar 2020
-
An update on the MS Leaders Academy
-
-
Data from Phase III Trial “SPI2” for Treatment of Progressive MS
-
Posted in Industry News
-
11th Mar 2020
-
News from MedDay Pharma
-
-
EU approval of Mayzent® (siponimod) for adult patients with secondary progressive multiple sclerosis (SPMS) with active disease
-
Posted in Industry News
-
21st Jan 2020
-
News from Novartis on the EU approval of Mayzent (siponimod) for adult patients with SPMS with active disease
-
-
Ocrelizumab (Ocrevus®) accepted for use in PPMS within NHS Scotland
-
Posted in Industry News
-
14th Jan 2020
-
Industry news from Roche
-
-
Creating clinical leaders, transformation pioneers and innovation specialists: because change starts from the ground up
-
Posted in Industry News
-
10th Dec 2019
-
Those of us in the room have the power we need to fundamentally improve the quality of multiple sclerosis (MS) care in the UK, reduce variation and offer consistent care at the level we want everywhere, in the next 3 years. In July, 85% of 120 healthcare professionals agreed with this statement (‘Raising the Bar’, […]
-
-
Multiple Sclerosis Patients in the UK to Receive Accelerated Access to MAVENCLAD® (Cladribine Tablets) Following Fast Tracked NICE Guidance Update
-
Posted in Industry News
-
05th Dec 2019
-
Industry news: patients with highly active MS will now have access to cladribine tablets without the additional requirement of a gadolinium-enhanced MRI, following review from NICE.
-
-
EMA approves interferon beta treatments, including Rebif (interferon beta-1a), for relapsing MS patients during pregnancy and breastfeeding
-
Posted in Industry News
-
22nd Oct 2019
-
News from Merck
-
-
An expert opinion: Optimisation of pharmacological management of multiple sclerosis related spasticity
-
Posted in Rehabilitation Articles
-
01st Oct 2019
-
Rachel Farrell and David Baker
-
-
New data from Biogen reinforce long-term benefits of Tecfidera® (Dimethyl Fumarate) over 10 years
-
Posted in Industry News
-
13th Sep 2019
-
News from Biogen at #ECTRIMS19
-
-
New Real-World Data Support Long-Term Efficacy and Safety Profile of MAVENCLAD®
-
Posted in Industry News
-
13th Sep 2019
-
News of Mavenclad from #ECTRIMS19
